Friday, May 24, 2024

65% of Gavi’s Investment Focused on Africa Despite 8.3 Million Zero-Dose Children, Reports Reveal

Gavi, the Vaccine Alliance, disclosed that Africa received 65% of its investment, facilitating the immunization of 438 million children and preventing over 11.3 million deaths.

The 2024 Africa Vaccination Week highlights Africa’s pivotal role in global immunization efforts. However, the continent still faces the challenge of 8.3 million zero-dose children, emphasizing the need for intensified immunization campaigns.

The report released by Gavi underscores critical areas demanding immediate attention from national and sub-national governments to enhance immunization delivery. Collaboration with global partners is vital to strengthen primary health care systems and implement innovative strategies to reach underserved areas. Securing adequate financing for immunization programs is crucial, as every dollar invested in immunization yields substantial returns, not only in healthcare savings but also in broader societal benefits.

Moreover, strengthening primary health care systems is essential for effective vaccine distribution, surveillance, and community engagement. Encouraging local vaccine manufacturing in Africa further enhances sustainability and self-reliance in vaccine supply, particularly considering the challenges exposed by the COVID-19 pandemic. Efforts such as the African Vaccine Manufacturing Accelerator aim to bolster local production and reduce reliance on external sources.

Sustaining investments in vaccines and immunization programs is paramount to ensure equitable access to life-saving vaccines for every child, regardless of their socio-economic status or geographical location.

Related Articles

Latest Articles

Most Popular